MaxCyte Streamlines Operations and Boosts Revenue Guidance for 2024
Welcome to MaxCyte, Inc. Operational Review Article What the Internal Operational Review Means for MaxCyte, Inc. Optimizing Efficiency and Aligning Resources MaxCyte, Inc., a leading cell-engineering focused company, recently announced the completion of an internal operational review. This review, initiated earlier this year after the appointment of Maher Masoud as President and CEO, aimed to…